Pinto, Bruna G. G; Oliveira, Antonio Edson Rocha; Singh, Youvika; Gonçalves, André Nicolau Aquime 
; Ogava, Rodrigo L. T; Creighton, Rachel; Peron, Jean Pierre Schatzmann ; Nakaya, Helder Takashi Imoto
Source: Journal of Infectious Diseases. Unidades: ICB, FCF
Subjects: ANGIOTENSINAS, COVID-19, COMORBIDADE, GENES, IMUNOLOGIA, INFECÇÕES RESPIRATÓRIAS, PNEUMOPATIAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Bruna G. G et al. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. Journal of Infectious Diseases, v. 222, p. 556-563, 2020Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiaa332. Acesso em: 05 nov. 2024.APA
Pinto, B. G. G., Oliveira, A. E. R., Singh, Y., Gonçalves, A. N. A., Ogava, R. L. T., Creighton, R., et al. (2020). ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. Journal of Infectious Diseases, 222, 556-563. doi:10.1093/infdis/jiaa332NLM
Pinto BGG, Oliveira AER, Singh Y, Gonçalves ANA, Ogava RLT, Creighton R, Peron JPS, Nakaya HTI. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19 [Internet]. Journal of Infectious Diseases. 2020 ; 222 556-563.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1093/infdis/jiaa332Vancouver
Pinto BGG, Oliveira AER, Singh Y, Gonçalves ANA, Ogava RLT, Creighton R, Peron JPS, Nakaya HTI. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19 [Internet]. Journal of Infectious Diseases. 2020 ; 222 556-563.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1093/infdis/jiaa332
